Those include tradipitant, which is under FDA review for delayed gastric emptying (gastroparesis) and in phase 3 for motion sickness, as well as Fanapt follow-up milsaperdone, which is due to be ...
After hours: February 7 at 7:23:36 PM EST ...
After hours: February 7 at 7:23:36 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback